{"id":"https://genegraph.clinicalgenome.org/r/cad5deb7-668a-47a5-ba7c-5f333c8586fcv1.0","type":"EvidenceStrengthAssertion","dc:description":"​​The ZMPSTE24 gene is located on chromosome 1 at 1p34.2 and encodes the zinc metallopeptidase STE24 protein, an integral membrane protein crucial for the final step in the biogenesis of lamin A (encoded by LMNA), a structural protein component of the nuclear lamina involved in nuclear shape, nuclear pore complex spacing, and resistance to mechanical stress.\nZMPSTE24 was first reported in relation to autosomal recessive lethal restrictive dermopathy in 2005 (Navarro et al., 2005 PMID:15843403). Lethal restrictive dermopathy is a congenital onset disorder that is lethal in the perinatal period (stillbirth or newborn death within the first week of life). It is characterized by rigid, translucent and tightly adherent skin with erosions and scaling, facial dysmorphism (small mouth, small pinched nose, and micrognathia), arthrogryposis multiplex/fetal akinesia or hypokinesia deformation sequence (FADS), thin dysplastic bipartite clavicles, overtubulated long bones, and pulmonary hypoplasia.\nVariants in ZMPSTE24 have  also been reported in association with the related non-lethal progeroid disorders, mandibuloacral dysplasia with type B lipodystrophy (MADB) and Hutchinson-Gilford progeria syndrome (HGPS). In vitro studies with recombinant mutated ZMPSTE24 demonstrate that the severity of the pathology caused by ZMPSTE24 variants correlates with the residual enzymatic activity of the mutated enzyme (Barrowman et al., 2012 PMID:22718200). Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found there was sufficient phenotypic variability and differences in the molecular mechanisms to support splitting these disorders into two distinct disease entities: lethal restrictive dermopathy (OMIM: 275210), and mandibuloacral dysplasia with type B lipodystrophy (OMIM: 608612) lumped with Hutchinson-Gilford progeria syndrome. Autosomal recessive mandibuloacral dysplasia with type B lipodystrophy has been curated separately.\nSix variants (frameshift, nonsense, and splice) that have been reported in 5 probands across 5 publications (Morais et al., 2009 PMID:19020898, Lu et al., 2013 PMID:23597553, Jagadeesh et al., 2009 PMID:19383993, Sander et al., 2008 PMID:18671782, Smigiel et al., 2010 PMID:20101687) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 points) has been reached. The mechanism of pathogenicity is known to be complete loss of function.\nThis gene-disease relationship is also supported by animal models and in vitro functional assays (Pendas et al., 2002 PMID:11923874, Sander et al., 2008 PMID:18671782, Moulson et al., 2005 PMID:16297189). In particular, in vitro assays using patient cells demonstrate an accumulation of prelamin A that is absent in healthy control cells (PMIDs:18671782, 16297189). Knockout mice display abnormalities overlapping with those of mice lacking A/C-type lamin and with human phenotypes related to lamin A deficiencies (PMID:11923874).\nIn summary, ZMPSTE24 is definitively associated with autosomal recessive lethal restrictive dermopathy. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.\nThis classification was approved by the ClinGen Syndromic Disorders Gene Curation Expert Panel on the meeting date 06.02.2021 (SOP Version 8).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/cad5deb7-668a-47a5-ba7c-5f333c8586fc","GCISnapshot":"https://genegraph.clinicalgenome.org/r/a85a92bd-afed-4e4e-99a5-e9902993c62e","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/a85a92bd-afed-4e4e-99a5-e9902993c62e_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2022-06-23T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/a85a92bd-afed-4e4e-99a5-e9902993c62e_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10060","date":"2022-06-30T16:13:26.643Z","role":"Publisher"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a85a92bd-afed-4e4e-99a5-e9902993c62e_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d2b55bd7-1cc7-4323-9ae9-6d8f5334bab6_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ffa400c-39b9-439c-a7c1-4dc221944e0d","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ffa400c-39b9-439c-a7c1-4dc221944e0d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Experimental data shows variant is completely inactive.\n(Barrowman PMID: 22718200)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1ffa400c-39b9-439c-a7c1-4dc221944e0d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19020898","allele":{"id":"https://genegraph.clinicalgenome.org/r/00e3adf2-666e-4f21-abb6-5f37c0efb9aa","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005857.4(ZMPSTE24):c.1085dupT (p.Leu362Phefs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116749"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/d2b55bd7-1cc7-4323-9ae9-6d8f5334bab6","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19020898","rdfs:label":"Mor-1","ageType":"AgeAtDeath","ageUnit":"Days","ageValue":9,"allele":{"id":"https://genegraph.clinicalgenome.org/r/00e3adf2-666e-4f21-abb6-5f37c0efb9aa"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Born 33/40. Rigid, translucent and tightly adherent skin, visible superficial vessels, dysmorphic facies (hyperthelorism, absent eyelashes, eyebrows, and hair in frontoparietal area, small pinched nose, microstomia, retromicrognathia, multiple joint contractures and radiological abnormalities. ","previousTesting":false,"sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/1ffa400c-39b9-439c-a7c1-4dc221944e0d_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/021ecdeb-7374-40d0-aef2-5e748b49f421_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46c70e2f-d495-489f-9c0a-7f1fa6b3bc85","type":"EvidenceLine","calculatedScore":4,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/46c70e2f-d495-489f-9c0a-7f1fa6b3bc85_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Experimental data shows variant is completely inactive.\n(Barrowman PMID: 22718200)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/46c70e2f-d495-489f-9c0a-7f1fa6b3bc85_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18671782","allele":{"id":"https://genegraph.clinicalgenome.org/r/e49ba7c5-f6cf-4b8a-87d5-b9462fb03c89","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005857.5(ZMPSTE24):c.627+1G>C","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA232753"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/021ecdeb-7374-40d0-aef2-5e748b49f421","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18671782","rdfs:label":"San-1","ageType":"AgeAtDeath","ageUnit":"Days","ageValue":45,"allele":{"id":"https://genegraph.clinicalgenome.org/r/e49ba7c5-f6cf-4b8a-87d5-b9462fb03c89"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Born 31/40. Large anterior fontanelle,\nmicrognathia, microstomia. Thin, fragile and shiny skin with prominent\nVeins, marked joint contractures, small thoracic cavity, thin ribbon-like ribs. Required mechanically ventilation until death from respiratory insufficiency","previousTesting":true,"previousTestingDescription":"LMNA Sanger","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/46c70e2f-d495-489f-9c0a-7f1fa6b3bc85_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/b5908cd5-70be-46bd-9b39-d9216a8fe915_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d49f4a29-9b11-44cc-bb29-17e7ba5eae72","type":"EvidenceLine","dc:description":"Minus 0.5 points for homozygous and -0.5 points for consanguinity not excluded. (2 points total)","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d49f4a29-9b11-44cc-bb29-17e7ba5eae72_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23597553","allele":{"id":"https://genegraph.clinicalgenome.org/r/8e73800a-0209-42c7-b77b-679f0dec5279","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005857.5(ZMPSTE24):c.715G>T (p.Glu239Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA116757"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/b5908cd5-70be-46bd-9b39-d9216a8fe915","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23597553","rdfs:label":"Lu-1","ageType":"AgeAtDeath","ageUnit":"Weeks","ageValue":33,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8e73800a-0209-42c7-b77b-679f0dec5279"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Stillborn. Rigid, tight, translucent skin with prominent vessels, absence of eyebrows and eyelashes, micrognathia with an “O”-shaped mouth, low pinched nose, contracture and immovability in multiple joints, clavicular hypoplasia\n\nSimilarly affected sister died at age 16 days","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d49f4a29-9b11-44cc-bb29-17e7ba5eae72_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ad78ddce-3862-4d73-8107-68c88919943d_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a87adaa3-a3e1-449a-a124-e05a611a0e85","type":"EvidenceLine","dc:description":"Minus 0.5 points for homozygous variant and minus 0.5 points for consanguinity not excluded, for 2 points total.","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a87adaa3-a3e1-449a-a124-e05a611a0e85_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19383993","allele":{"id":"https://genegraph.clinicalgenome.org/r/f16a3f8f-fc7c-4d9e-95ae-f093348e89f1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005857.5(ZMPSTE24):c.691G>T (p.Glu231Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA232757"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/ad78ddce-3862-4d73-8107-68c88919943d","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19383993","rdfs:label":"Jag-1","ageType":"AgeAtDeath","ageUnit":"Days","ageValue":2,"allele":{"id":"https://genegraph.clinicalgenome.org/r/f16a3f8f-fc7c-4d9e-95ae-f093348e89f1"},"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Born 32/40. Small eyes and nose, low set ears and open mouth. Dolicocephalic head with open sutures and wide open anterior fontanelle. Taut skin, parched and peeling in patches. Stiff joints and limbs with restriction of movements. Dysplastic clavicles.\n\nSimilarly affected sibling\n","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/a87adaa3-a3e1-449a-a124-e05a611a0e85_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/4f1ade54-f439-4224-a988-667cb4a1f229_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5995b1fa-73b2-47e2-81ec-64aae52fcd09","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5995b1fa-73b2-47e2-81ec-64aae52fcd09_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20101687","allele":{"id":"https://genegraph.clinicalgenome.org/r/e52705c2-436d-4a9f-8fbb-56c8bbe3d51d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005857.5(ZMPSTE24):c.50del (p.Lys17fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA213066"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/bd5e7a83-cc38-4de1-ae00-7a0b7fb1e38b","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd5e7a83-cc38-4de1-ae00-7a0b7fb1e38b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20101687","allele":{"id":"https://genegraph.clinicalgenome.org/r/88c27a65-53bb-4312-81b3-462ba71dcfd2","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_005857.5(ZMPSTE24):c.584_585del (p.Tyr195fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA213067"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/4f1ade54-f439-4224-a988-667cb4a1f229","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/20101687","rdfs:label":"Smi-1","ageType":"AgeAtDeath","ageUnit":"Days","ageValue":7,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/88c27a65-53bb-4312-81b3-462ba71dcfd2"},{"id":"https://genegraph.clinicalgenome.org/r/e52705c2-436d-4a9f-8fbb-56c8bbe3d51d"}],"firstTestingMethod":"Sanger sequencing","phenotypeFreeText":"Born 32/40. Growth retardation, hypertelorism, small, pinched nose, micrognathia, mouth fixed in the ‘‘o’’\nposition. Thin, rigid and tense skin with erosions and scaling, prominent skin vessels, multiple joints contractures, camptodactyly, absent or small nails,\nrocker-bottom feet, narrow chest, hypoplasia of the shoulder girdle\n\nSimilarly affected brother\n","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/bd5e7a83-cc38-4de1-ae00-7a0b7fb1e38b_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/5995b1fa-73b2-47e2-81ec-64aae52fcd09_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/a85a92bd-afed-4e4e-99a5-e9902993c62e_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a85a92bd-afed-4e4e-99a5-e9902993c62e_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dc47aec5-c7fc-473d-abc0-c8556e9856cf","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c77d64de-4b8d-40d1-8492-5092ba35b25d","type":"Finding","dc:description":"Abnormalities overlap with those of mice lacking A/C-type lamin and human phenotypes related to lamin A deficiencies. Mouse model is less severe than human phenotype lacking characteristic dermal features.\nBetter model of MADB","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11923874","rdfs:label":"Zmpste24 KO mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/a85a92bd-afed-4e4e-99a5-e9902993c62e_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bd5e53a9-bc6d-42ec-8218-137bae6cfb47","type":"EvidenceLine","dc:description":"Evidence accumulated across multiple similar experiments","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e2609a44-a976-45f3-961c-16cea8035ad7","type":"FunctionalAlteration","dc:description":"Immunocytochemistry shows that patient cells exhibit an accumulation of prelamin A at the nuclear periphery and within nuclear foci, that is absent in healthy control cells\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/18671782","rdfs:label":"Prelamin A accumulation - Immunocytochemistry"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f99f74a4-a94d-4f60-b39e-f5559ea378df","type":"EvidenceLine","dc:description":"Evidence accumulated across multiple similar experiments","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/f9d0df0d-9028-4fc6-be6d-64c44d9b3148","type":"FunctionalAlteration","dc:description":"Immunocytochemistry shows that patient cells exhibit an accumulation of prelamin A at the nuclear periphery and within nuclear foci, that is absent in healthy control cells\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16297189","rdfs:label":"Prelamin A accumulation - Immunocytochemistry"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3}],"evidenceStrength":"Definitive","sequence":4675,"specifiedBy":"GeneValidityCriteria8","strengthScore":15,"subject":{"id":"https://genegraph.clinicalgenome.org/r/brjEY6aoCIM","type":"GeneValidityProposition","disease":"obo:MONDO_0010143","gene":"hgnc:12877","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_a85a92bd-afed-4e4e-99a5-e9902993c62e-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}